Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000524706 | SCV000629388 | benign | Spastic paraplegia | 2024-03-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314948 | SCV000848965 | benign | Inborn genetic diseases | 2017-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001653889 | SCV001869658 | benign | not provided | 2018-09-10 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26891472, 19846429) |
Athena Diagnostics | RCV001662537 | SCV001879554 | benign | not specified | 2021-04-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002497076 | SCV002805404 | likely benign | MASA syndrome; X-linked complicated corpus callosum dysgenesis; X-linked hydrocephalus syndrome | 2021-07-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003960269 | SCV004768684 | likely benign | L1CAM-related disorder | 2023-12-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |